Sutro Biopharma (STRO)
(Real Time Quote from BATS)
$1.92 USD
-0.01 (-0.52%)
Updated Dec 26, 2024 11:36 AM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/24/25 |
---|---|
Current Quarter | -0.86 |
EPS Last Quarter | -0.59 |
Last EPS Surprise | 20.27% |
ABR | 1.18 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.92 |
Next Year | -2.95 |
EPS (TTM) | -1.71 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.44M | 15.00M | 56.18M | 61.38M |
# of Estimates | 6 | 2 | 7 | 6 |
High Estimate | 20.00M | 15.00M | 67.23M | 115.19M |
Low Estimate | 1.76M | 15.00M | 47.20M | 30.93M |
Year ago Sales | 113.72M | 13.01M | 153.73M | 56.18M |
Year over Year Growth Est. | -90.82% | 15.30% | -63.46% | 9.26% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.86 | -0.86 | -2.92 | -2.95 |
# of Estimates | 9 | 3 | 9 | 9 |
Most Recent Consensus | -0.68 | -0.82 | -2.75 | -3.57 |
High Estimate | -0.68 | -0.82 | -2.43 | -2.01 |
Low Estimate | -1.13 | -0.92 | -3.24 | -3.73 |
Year ago EPS | 0.42 | -0.95 | -1.91 | -2.92 |
Year over Year Growth Est. | -304.76% | 9.47% | -52.88% | -1.16% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 6 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 6 | 1 | 2 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.86 | -0.86 | -2.92 | -2.95 |
7 Days Ago | -0.86 | -0.86 | -2.92 | -2.95 |
30 Days Ago | -0.86 | -0.86 | -2.92 | -2.96 |
60 Days Ago | -0.75 | -0.88 | -2.96 | -2.90 |
90 Days Ago | -0.75 | -0.88 | -2.96 | -2.90 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.86 | -0.86 | -3.22 | -2.93 |
Zacks Consensus Estimate | -0.86 | -0.86 | -2.92 | -2.95 |
Earnings ESP | 0.00% | 0.00% | -10.44% | 0.66% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.59 | -0.59 | -0.95 | 0.42 | NA |
Estimate | -0.74 | -0.76 | -0.92 | -0.82 | NA |
Difference | 0.15 | 0.17 | -0.03 | 1.24 | 0.38 |
Surprise | 20.27% | 22.37% | -3.26% | 151.22% | 47.65% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more